FLAW
发表于 2025-3-21 17:32:28
书目名称Biopatent Law: Patent Strategies and Patent Management影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0188308<br><br> <br><br>书目名称Biopatent Law: Patent Strategies and Patent Management读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0188308<br><br> <br><br>
谷物
发表于 2025-3-21 22:33:30
http://reply.papertrans.cn/19/1884/188308/188308_2.png
MIME
发表于 2025-3-22 01:20:38
http://reply.papertrans.cn/19/1884/188308/188308_3.png
古老
发表于 2025-3-22 04:37:02
Biopatent Law: Patent Strategies and Patent Management978-3-642-24846-7Series ISSN 2192-9904 Series E-ISSN 2192-9912
FAZE
发表于 2025-3-22 11:34:56
http://reply.papertrans.cn/19/1884/188308/188308_5.png
chisel
发表于 2025-3-22 13:33:20
http://reply.papertrans.cn/19/1884/188308/188308_6.png
手工艺品
发表于 2025-3-22 18:57:33
https://doi.org/10.1007/978-3-642-24846-7Biopharmaceutics; Intellectual properties; Invention; Litigation strategies; Patent infringement
chiropractor
发表于 2025-3-23 00:53:08
https://doi.org/10.1007/978-3-662-46444-1ed requirements. However, unique requirements were established such that the peculiarities of biotechnological inventions can be considered. Nonetheless, it appears that certain specific regulations for obtaining patent protection for a biotechnological invention poses more burden to an applicant th
方舟
发表于 2025-3-23 02:33:39
https://doi.org/10.1007/978-3-662-43205-1ategies both from an active viewpoint as claimant and a passive viewpoint as a respondent. Active and passive will be interpreted with respect to an intellectual pro perty rights (IPR) portfolio and it will be interpreted in light of actions performed with respect to an IPR portfolio. Both views hav
propose
发表于 2025-3-23 06:23:07
Laser Speckle and Related Phenomenad into research and development, their lifetime is restricted. However, due to lengthy authorisation processes for pharmaceutical products, biopharmaceutic innovators cannot exploit the full lifetime of their patents. In order to provide sufficient incentive to develop new drugs, all major countries